Ecuador Medical Device Market Access 2026: From Registration to Distribution
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Three separate gates must be cleared before a medical device can lawfully circulate after import into Ecuador: the sanitary registration certificate at the product level (Article 5), the operating permit at the establishment level (Article 60), and the good practices certification for the circulation stage (transitory general provision six, BPADT). The three obligations rest on different liable subjects and different legal documents, and if any one of them is missing, the product cannot circulate lawfully.
2. Legal basis
| Regulation | Reference number | Publication date | Article provisions |
|---|---|---|---|
| Substitute Technical Sanitary Regulation for the Registration, Control and Surveillance of Medical Devices for Human Use | Resolución ARCSA-DE-2026-003-DASP | Signed 2026-04-28 | Article 5 (mandatory registration), Article 60 (operating permit) |
| Same regulation | Same | Same | Transitory general provision six (BPADT), Article 71 (retention of distributor authorizations) |
| Same regulation | Same | Same | Article 1 (legislative purpose), Article 2 (scope of application) |
| Parent regulation on good practices for storage, distribution and transport | Resolución ARCSA-DE-002-2020-LDCL, Registro Oficial Edición Especial 455 | 2020-03-19 | Full text |
Verification note: the new regulation (ARCSA-DE-2026-003-DASP) governs product registration and sanitary surveillance and does not regulate the specific customs clearance procedures or documentation requirements. Clearance is administered by the National Customs Service of Ecuador (SENAE) under its own rules. This article cites only the three gates expressly provided for in the new regulation; the operational details of clearance follow the rules currently issued by SENAE.
3. Expert insights
Insight 1: The three gates bind different subjects, and the obligations are easily mismatched. The distinction is not academic: each gate is documented separately, renewed separately and verified by the authority separately, so an importer that organizes compliance around the product alone will leave the other two gates unowned.
- Registration certificate: the registration holder is the liable subject (Articles 5 and 19);
- Operating permit: the establishment engaged in manufacturing, import, distribution, storage or commercialization is the liable subject (Article 60);
- BPADT: the establishment that stores, distributes or transports the devices is the liable subject (transitory general provision six).
Manufacturers from the Chinese mainland typically watch only the first gate, yet it is the other two that most often explain goods arriving at port but unable to enter the warehouse.
Insight 2: Article 2 extends the scope of application to every relevant party. The text provides that the regulation is mandatory for all natural or legal persons applying for registration, renewal or change, whether domestic or foreign, and whether public or private. The liable subjects are not limited to the registration holder. For a foreign manufacturer this matters in two directions: it cannot outsource its way out of the regime by pointing at the local holder, and every local party it appoints, from the holder to the distributor, is independently caught by the same obligations.
Insight 3: Article 71 adds an on-site verification duty in the distribution stage. The legal representative or technical director of device representative offices and distributors must retain at the premises the authorization of the registration holder for distribution and commercialization, available for verification by ARCSA during surveillance and inspection. Under this requirement, verbal or email-only authorizations will not be accepted in an inspection. Inspectors work from the documents physically present at the establishment, so the authorization must be printed, signed, dated and kept where it can be produced immediately during a visit.
Insight 4: Article 1 sets out the three elements of the legislative purpose. The text establishes the legal and technical requirements to guarantee quality, safety and efficacy, on whose basis the registration certificates are issued (registration, change and renewal), together with the standards for the control and surveillance of these products. Control and surveillance stand alongside registration, which shows that the post-market stage carries the same weight as the pre-market stage.
Insight 5: The consequences of failure differ across the three gates. Where a registration certificate is suspended or cancelled, transitory general provision two implies prohibitions on manufacture, import and export, immediate market withdrawal and confiscation; where an operating permit lapses, the establishment may no longer carry out the covered activities; and where BPADT lapses, storage, distribution and transport become non-compliant. The three failures also differ in how quickly they can be remedied, since a permit or a BPADT certification follows its own renewal cycle, which is why the ledger recommended below tracks all three on the same calendar.
4. Practical recommendations
- Build a triple compliance ledger covering product, establishment and circulation, recording the certificate numbers, validity periods and liable subjects separately.
- Check all three items simultaneously when vetting a channel partner: the registrations held in its name, the operating permit and the BPADT certification.
- Keep the distribution authorization in written form at the distributor’s premises, to satisfy the on-site verification of Article 71.
- Set expiry alerts for all three certificates, and pause shipments the moment any one of them lapses, since a shipment released against a lapsed document cannot be cured retroactively.
- Confirm clearance details with SENAE or a local customs broker, and do not merge them with the ARCSA registration requirements.
5. Verification checklist
- □ The product registration certificate is valid and the holder information is correct
- □ The import and warehousing establishment holds a valid operating permit
- □ The storage, distribution and transport establishments hold valid BPADT certification
- □ The distributor’s premises retain the written distribution authorization of the holder
- □ Expiry alerts have been configured for all three certificates
- □ The clearance process has been confirmed with SENAE or a customs broker
Regulatory information verified as of October 29, 2026
GRZAN service note
GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, end-to-end compliance across registration, operating permit and BPADT requirements, licensing structure design, official fee and timeline estimation, technical dossier preparation, and post-market compliance management. Manufacturers and importers mapping the full route from registration to distribution in Ecuador may contact GRZAN at info@grzanglobal.com for a tailored solution.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us